Article
Analysis of HIV-1 latent reservoir and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117
2018-05-25
Abstract excerpt
A clinical trial was performed to evaluate 3BNC117, a potent anti_HIV_1 antibody, in infected individuals during suppressive antiretroviral therapy (ART) and subsequent analytical treatment interruption (ATI). The circulating reservoir was evaluated by quantitative and qualitative outgrowth assay (Q 2 VOA) at entry and after 6 months, prior to ATI. Although there were no significant quantitative changes in the si...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2112ff24-98d1-5121-bb03-b96e381ef4a1
- DOI
- 10.1101/324509
